Pierre Démolis

The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use

Marta Kollb-Sielecka, Pierre Démolis, Joseph Emmerich et al. · Sleep Medicine · 2017 · 244 citations

Human Use, Psychoactive Drug, Psychotropic Medication +7

Evolution of the Postoperative Pericardial Effusion After Day 15: The Problem of the Late Tamponade

Philippe Meurin, Hélène Weber, Nathalie Renaud et al. · CHEST Journal · 2004 · 91 citations

Heart Failure, Cardiogenic Shock, Cardiac Anaesthesia +9

Vascular reactivity in acromegalic patients: preliminary evidence for regional endothelial dysfunction and increased sympathetic vasoconstriction

Patrick Maison, Pierre Démolis, Jacques Young et al. · Clinical Endocrinology · 2000 · 77 citations

ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients

Andrew D.J. Pearson, Claudia Rössig, Giovanni Lesa et al. · European Journal of Cancer · 2020 · 66 citations · Full text

The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

Maria Nieto, Pierre Démolis, Eliane Béhanzin et al. · The Oncologist · 2016 · 58 citations · Full text